SENSEX NIFTY

Glaxosmithkline Pharmaceuticals Ltd

Aug 26, 2016 at 13:08 | Source: Moneycontrol.com
Beryl Drugs Ltd has informed BSE that the 23rd Annual General Meeting (AGM) of the Company was held on August 26, 2016.
Aug 26, 2016 at 10:24 | Source: Moneycontrol.com
Natural Capsules Ltd has informed BSE regarding Outcome of Board Meeting held on August 26, 2016.
Aug 26, 2016 at 08:29 | Source: Moneycontrol.com
Nutraplus India Ltd has informed BSE that the meeting of the Allotment Committee of the Company was held on August 25, 2016.
Aug 25, 2016 at 12:26 | Source: Moneycontrol.com
Nutraplus India Ltd has informed BSE that the 26th Annual General Meeting (AGM) of the Company will be held on September 15, 2016.
Aug 25, 2016 at 12:25 | Source: Moneycontrol.com
Combat Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 25, 2016, decided to hold the 30th Annual General Meeting of the company on the September 29, 2016.
Aug 25, 2016 at 09:31 | Source: CNBC-TV18
In an interview to CNBC-TV18, Mayuresh Joshi, Fund Manager (PMS) at Angel Broking Ltd shared his readings and outlook on specific stocks and sectors.
Aug 24, 2016 at 15:20 | Source: Moneycontrol.com
Neuland Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 27, 2016, to consider a proposal to merge Neuland Health Sciences and Neuland Pharma Research with Neuland Laboratories.
Aug 24, 2016 at 13:21 | Source: Moneycontrol.com
Ortin Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on August 29, 2016, to consider the proposal of demerger of the business of the Company.
Aug 24, 2016 at 12:26 | Source: Moneycontrol.com
Saamya Biotech India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 31, 2016.
Aug 24, 2016 at 08:46 | Source: Moneycontrol.com
Jubilant Life Sciences Ltd has received Abbreviated New Drug Application (ANDA) final approval for Telmisartan Tablets, USP 20,40 and 80mg, the generic version of Micardis Tablets of Boehringer Ingelheim Pharmaceuticals Inc., which is used for the treatment of hypertension.
Messages on Glaxosmithkline Pharmaceuticals Ltd »

Web Messenger

Platinum Member

362239 Followers

DLF  

Source:Wall Street Journal - By KHUSHITA VASANT MUMBAI -- The Bombay Stock Exchange will replace real-estate developer DLF Ltd. with Dr. Reddy's Laboratories Ltd. in its 30-share benchmark Sensitive Index. The exchange will also replace Glaxosmithkline Pharmaceuticals Ltd. from

2.09 PM Apr 23rd 2012

Web Messenger

Platinum Member

362239 Followers

Dr Reddys Labs  

Source:Wall Street Journal - By KHUSHITA VASANT MUMBAI -- The Bombay Stock Exchange will replace real-estate developer DLF Ltd. with Dr. Reddy's Laboratories Ltd. in its 30-share benchmark Sensitive Index. The exchange will also replace Glaxosmithkline Pharmaceuticals Ltd. from

2.09 PM Apr 23rd 2012

News across the web »
Feb 18, 2014 at 10:41 | Source: Economic Times
Feb 18, 2014 at 08:26 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.